Page last updated: 2024-08-23

norgestimate and ethinyl estradiol

norgestimate has been researched along with ethinyl estradiol in 92 studies

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-19908 (8.70)18.7374
1990's38 (41.30)18.2507
2000's36 (39.13)29.6817
2010's7 (7.61)24.3611
2020's3 (3.26)2.80

Authors

AuthorsStudies
Lawson, JS; Osterman, JJ; Pasquale, SA; Yuliano, SE1
Gonzales-Ansorena, R; Rubio-Lotvin, B1
Abrams, LS; McGuire, JL; Patrick, JE; Weintraub, HS1
Anderson, FD1
Andolsek, KM1
Dain, MP; Gauthier, A; Upmalis, D1
Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J1
Gillmer, MD1
Grunwald, K; Rabe, T; Runnebaum, B1
Huber, J1
Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B1
Back, DJ; Rudland, PS; Wild, MJ2
Chapdelaine, A; Derman, RJ; Desmarais, JL1
Back, DJ; Madden, S; Orme, ML1
Corson, SL1
Chez, RA1
Rabe, T; Runnebaum, B1
Lane, PA; Mayberry, DO; Young, RW1
Hull, ME; Moghissi, KS1
Borin, K; Moghissi, KS; Mohsenian, M1
Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R1
Jung-Hoffmann, C; Kuhl, H; Wiegratz, I1
Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF1
Affinito, P; Di Carlo, C; Farace, MJ; Monterubbianesi, M; Nappi, C; Petrillo, G; Primizia, M; Regine, V1
Blode, H; Kuhnz, W; Mahler, M1
Andolsek, KM; Burkman, RT; Kafrissen, ME; Olson, W; Osterman, J1
Anderson, FD; Gillmer, MD1
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D1
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM1
Teichmann, A1
Creinin, MD1
Lox, CD2
Handler, S; Huber, J; Kapiotis, S; Loner, U; Quehenberger, P; Schneider, B; Speiser, W1
Jones, TM; Jorizzo, JL; Kafrissen, ME; Lippman, JS; Olson, WH; Redmond, GP1
Stanczyk, FZ1
Henderson, TA; Lebwohl, M; Lucky, AW; Olson, WH; Robisch, DM; Swinyer, LJ1
Gross, W; Jung-Hoffmann, C; Kuhl, H; Wiegratz, I1
Redmond, GP1
Charkoudian, N; Johnson, JM1
Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P1
Chroust, K; Cibula, D; Horejsí, J; Paseka, J; Rotta, L; Unzeitig, V1
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO1
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S1
Davis, A; Godwin, A; Kafrissen, M; Lippman, J; Olson, W1
Chroust, K; Cibula, D; Paseka, J; Unzeitig, V1
Bancroft, J; Bass, JL; Graham, CA; Sanders, SA1
Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA1
Zieman, M1
Abrams, LS; Natarajan, J; Skee, D; Wong, FA1
Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W1
Taneepanichskul, S; Tantbirojn, P1
Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK1
Hönigsmann, H; Sator, PG; Schmidt, JB1
Eterović, D; Strinić, T1
Fisher, A; Friedman, A; Kafrissen, M; LaGuardia, KD; Shangold, G1
Friedman, AJ; Grinspoon, SK; Lippman, J; Miller, KK; Olson, WH; Warren, MP1
Kaunitz, AM1
del Marmol, V; Gertsen, K; Teichmann, A1
Baerwald, AR; Olatunbosun, OA; Pierson, RA1
Jain, JK; Stanczyk, FZ; White, T1
Friedman, AJ; Grinspoon, SK; Miller, KK; Olson, WH; Warren, MP1
O'Connell, KJ; Osborne, LM; Westhoff, C1
Jick, H; Jick, SS; Kaye, JA; Russmann, S1
Brenner, P1
Burrows, M; Peters, C1
Cole, JA; Doherty, M; Norman, H; Walker, AM1
Bettenhausen, DK; Connolly, M; Forbes, WP; Pentikis, H; Trapnell, CB1
Devineni, D; Janssens, L; LaGuardia, KD; Leung, AT; Massarella, J; Skee, D; Vaccaro, N1
Jick, H; Jick, S; Kaye, JA; Li, L1
Bancroft, J; Doll, HA; Graham, CA; Greco, T; Tanner, A1
Tan, JK1
Burkman, RT; Fisher, AC; LaGuardia, KD1
De Souza, MJ; VanHeest, JL; Vescovi, JD1
Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S1
Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF1
Banárová, A; Koller, T; Kollerová, J; Ondrias, F; Payer, J1
Buono, MJ; Martin, JG1
Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ1
Bertz, R; Eley, T; Garner, D; Krantz, K; Nettles, R; Persson, A; Sevinsky, H; Yones, C; Zhang, J1
Bertz, R; Chung, E; Eley, T; Mahnke, L; Persson, A; Xu, X; Yones, C; Zhang, J1
Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS1
Backos, A; Bartlett, H; Callaghan, JH; Callaghan, MU; Chitlur, M; Marshall, S; Rajpurkar, M; Sawni, A; Zia, A1
Adeniji, AA; Cheang, KI; Essah, PA; Nestler, JE1
Chen, M; Huang, MQ; Kang, L; Lin, ZJ; Skee, D; Verhaeghe, T; Wang, W; Weng, N1
Fakayode, SO; Hordge, LN; Jones, DD; McDaniel, KL1
Chang, W; Dragoo, JL; Hsue, L; Konopka, JA; Thio, T1
Facchinetti, F; Grandi, G; Guariglia, G1
Bertz, RJ; Bhardwaj, R; Croop, RS; Morris, B; Stringfellow, JC1

Reviews

12 review(s) available for norgestimate and ethinyl estradiol

ArticleYear
Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Acne Vulgaris; Animals; Body Weight; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Meta-Analysis as Topic; Norgestrel; Prolactin; Receptors, Androgen; Receptors, Progesterone; Sex Hormone-Binding Globulin

1992
The European experience: an overview.
    International journal of fertility, 1992, Volume: 37 Suppl 1

    Topics: Contraceptives, Oral, Combined; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Europe; Female; Humans; Norgestrel; Progesterone Congeners

1992
Gastrointestinal metabolism of contraceptive steroids.
    American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2

    Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates

1990
Metabolic aspects of the new low-dose oral contraceptives.
    International journal of fertility, 1989, Volume: 34 Suppl

    Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins

1989
Norgestimate: overview of a monophasic formulation.
    International journal of fertility and menopausal studies, 1993, Volume: 38 Suppl 3

    Topics: Animals; Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Norgestrel; Ovulation; Progestins; Rabbits; Receptors, Androgen; Sex Hormone-Binding Globulin; Testosterone

1993
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
    Contraception, 1997, Volume: 55, Issue:5

    Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners

1997
Effectiveness of oral contraceptives in the treatment of acne.
    Contraception, 1998, Volume: 58, Issue:3 Suppl

    Topics: Acne Vulgaris; Adolescent; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Male; Norgestrel; Randomized Controlled Trials as Topic

1998
Pharmacokinetic overview of Ortho Evra/Evra.
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes

2002
Enhancing oral contraceptive success: the potential of new formulations.
    American journal of obstetrics and gynecology, 2004, Volume: 190, Issue:4 Suppl

    Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel

2004
The role of combined oral contraceptives in the management of acne and seborrhea.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2004, Volume: 9, Issue:2

    Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome

2004
New developments in hormonal therapy for acne.
    Skin therapy letter, 2007, Volume: 12, Issue:7

    Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel

2007
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2023, Volume: 28, Issue:3

    Topics: Acne Vulgaris; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel

2023

Trials

50 trial(s) available for norgestimate and ethinyl estradiol

ArticleYear
Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
    American journal of obstetrics and gynecology, 1979, Jun-01, Volume: 134, Issue:3

    Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Evaluation; Ethinyl Estradiol; Female; Gastrointestinal Diseases; Humans; Norgestrel; Pregnancy; Random Allocation; Uterine Hemorrhage

1979
Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Patient Compliance; Premenstrual Syndrome

1992
Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norgestrel; Patient Compliance; Pregnancy

1992
The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
    American journal of obstetrics and gynecology, 1992, Volume: 166, Issue:6 Pt 2

    Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Triglycerides

1992
Clinical experience with a new norgestimate-containing oral contraceptive.
    International journal of fertility, 1991, Volume: 36 Suppl 1

    Topics: Adult; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel

1991
[Side effects of oral contraceptives in the first treatment cycle].
    Wiener medizinische Wochenschrift (1946), 1991, Volume: 141, Issue:18-19

    Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies

1991
[Clinical evidence of the minimal androgenic activity of norgestimate].
    Revue francaise de gynecologie et d'obstetrique, 1990, Volume: 85, Issue:6

    Topics: Acne Vulgaris; Adult; Androgens; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Multicenter Studies as Topic; Norgestrel; Sex Hormone-Binding Globulin; Weight Gain

1990
Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1990, Volume: 152

    Topics: Adolescent; Adult; Cervix Mucus; Clinical Trials as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Multicenter Studies as Topic; Norgestrel; Ovulation; Sex Hormone-Binding Globulin; United States

1990
Ovarian function during low-dose oral contraceptive use.
    Contraception, 1995, Volume: 51, Issue:6

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography

1995
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Contraception, 1995, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Carrier Proteins; Contraceptives, Oral; Contraceptives, Oral, Combined; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone

1995
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
    Contraception, 1995, Volume: 51, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2

1995
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1993, Volume: 7, Issue:4

    Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Norgestrel; Norpregnenes

1993
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
    Contraception, 1994, Volume: 49, Issue:3

    Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel

1994
Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    International journal of fertility and menopausal studies, 1993, Volume: 38 Suppl 3

    Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Longitudinal Studies; Menstrual Cycle; Norgestrel; Triglycerides

1993
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

1995
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners

1995
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--I. chemistry profiles.
    General pharmacology, 1996, Volume: 27, Issue:2

    Topics: Adult; Blood Cell Count; Blood Chemical Analysis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Hematologic Tests; Humans; Norgestrel; Progestins; Women's Health

1996
Biochemical effects in women following one year's exposure to a new triphasic contraceptive--II. coagulation profiles.
    General pharmacology, 1996, Volume: 27, Issue:2

    Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Ethinyl Estradiol; Female; Humans; Norgestrel; Progestins; Protein C; Women's Health

1996
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Thrombosis and haemostasis, 1996, Volume: 76, Issue:5

    Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Factor VIIa; Female; Humans; Norgestrel; Norpregnenes; Prospective Studies; Protein S; Risk Factors; Thromboembolism; Thrombomodulin

1996
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Obstetrics and gynecology, 1997, Volume: 89, Issue:4

    Topics: Acne Vulgaris; Adolescent; Adult; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Prospective Studies

1997
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:5 Pt 1

    Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Middle Aged; Nausea; Norgestrel; Patient Participation; Prospective Studies; Respiratory Tract Infections; Treatment Outcome

1997
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Contraception, 1998, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Reference Values; Triglycerides

1998
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
    Contraception, 1999, Volume: 59, Issue:3

    Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction

1999
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
    Contraception, 1999, Volume: 59, Issue:6

    Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis

1999
[Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women].
    Ceska gynekologie, 1999, Volume: 64, Issue:4

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norgestrel; Patient Satisfaction; Pregnancy; Prospective Studies

1999
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
    Contraception, 1999, Volume: 60, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides

1999
Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.
    Obstetrics and gynecology, 2000, Volume: 96, Issue:6

    Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Norgestrel; Treatment Outcome

2000
[Liver function tests during administration of triphasic contraceptives containing Norgestimate].
    Ceska gynekologie, 2000, Volume: 65, Issue:6

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Liver Function Tests; Norgestrel; Prospective Studies

2000
A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation.
    Contraception, 2001, Volume: 64, Issue:1

    Topics: Adult; Affect; Analysis of Variance; Attitude; Contraception; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Logistic Models; Marriage; Norgestrel; Prospective Studies; Sexuality; Surveys and Questionnaires; Time Factors

2001
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
    Contraception, 2001, Volume: 64, Issue:5

    Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors

2001
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Contraception, 2002, Volume: 66, Issue:3

    Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone

2002
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Contraception, 2002, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage

2002
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
    Contraception, 2003, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

2003
Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.
    Contraception, 2003, Volume: 67, Issue:6

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norgestrel; Ovulation; Pregnancy; Progesterone; Racial Groups; Uterine Hemorrhage

2003
Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: Adolescent; Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Bone Resorption; Cognition; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypothalamic Diseases; Norgestrel

2003
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
    Contraception, 2004, Volume: 70, Issue:5

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography

2004
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome

2005
Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study.
    Contraception, 2005, Volume: 72, Issue:3

    Topics: Absorptiometry, Photon; Adolescent; Adult; Amenorrhea; Biomarkers; Bone Density; Bone Diseases, Metabolic; Contraceptives, Oral, Synthetic; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Hypothalamic Diseases; Lumbar Vertebrae; Norgestrel

2005
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
    Contraception, 2005, Volume: 72, Issue:5

    Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain

2005
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
    Contraception, 2006, Volume: 74, Issue:6

    Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports

2006
Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Rifamycins; Rifaximin; Therapeutic Equivalency

2007
Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Journal of clinical pharmacology, 2007, Volume: 47, Issue:4

    Topics: Abdomen; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Buttocks; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Half-Life; Humans; Middle Aged; Norgestrel; Oximes

2007
The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Contraception, 2007, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Affect; Androgens; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Norgestrel; Premenstrual Syndrome; Sex Hormone-Binding Globulin; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome

2007
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain

2007
Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Contraception, 2008, Volume: 77, Issue:2

    Topics: Adult; Amenorrhea; Biomarkers; Bone and Bones; Bone Resorption; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Energy Intake; Energy Metabolism; Ethinyl Estradiol; Exercise; Female; Humans; Hypothalamic Diseases; Norgestrel; Peptide Fragments; Procollagen; Prospective Studies

2008
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Obstetrics and gynecology, 2008, Volume: 111, Issue:2 Pt 1

    Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor

2008
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Contraception, 2008, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome

2008
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
    Clinical physiology (Oxford, England), 1997, Volume: 17, Issue:4

    Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature

1997
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
    Contraception, 2009, Volume: 79, Issue:6

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult

2009
Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
    Headache, 2023, Volume: 63, Issue:5

    Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Pyridines

2023

Other Studies

30 other study(ies) available for norgestimate and ethinyl estradiol

ArticleYear
Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Acta Europaea fertilitatis, 1978, Volume: 9, Issue:1

    Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstruation; Norgestrel

1978
Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans.
    Journal of pharmaceutical sciences, 1978, Volume: 67, Issue:10

    Topics: Administration, Oral; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Intestinal Absorption; Kinetics; Norgestrel

1978
Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Adolescent; Adult; Blood Glucose; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Lipids; Norgestrel

1992
Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 39, Issue:4A

    Topics: Breast; Breast Neoplasms; Cell Line; Contraceptives, Oral; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Norgestrel; Radioisotope Dilution Technique; Tritium; Tumor Cells, Cultured

1991
New progestogens in oral contraceptives.
    American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2

    Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners

1987
Determination of norgestimate and ethinyl estradiol in tablets by high-performance liquid chromatography.
    Journal of pharmaceutical sciences, 1987, Volume: 76, Issue:1

    Topics: Drug Stability; Ethinyl Estradiol; Norgestrel; Tablets

1987
Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1986, Volume: 2, Issue:1

    Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Norgestrel

1986
Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
    Contraception, 1981, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Body Temperature; Cervix Mucus; Ethinyl Estradiol; Female; Humans; Male; Menstruation; Norgestrel; Spermatozoa

1981
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 45, Issue:5

    Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured

1993
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires

1995
Laboratory criteria for menopause in women using oral contraceptives.
    Fertility and sterility, 1996, Volume: 66, Issue:1

    Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors

1996
Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins.
    The American journal of physiology, 1999, Volume: 276, Issue:5

    Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Combinations; Estradiol Congeners; Female; Heart Rate; Hot Temperature; Humans; Ibuprofen; Mestranol; Norethindrone; Norgestrel; Prostaglandins; Reflex; Skin; Stress, Physiological; Sweating; Vasodilation

1999
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:4

    Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis

2000
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
    Fertility and sterility, 2002, Volume: 77, Issue:2 Suppl 2

    Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins

2002
Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris. A pilot study.
    Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:3

    Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Pilot Projects; Prospective Studies; Treatment Outcome

2003
Less estrogen in new oral contraceptive.
    The American journal of nursing, 2003, Volume: 103, Issue:4

    Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel

2003
Oral contraceptives improve lung mechanics.
    Fertility and sterility, 2003, Volume: 79, Issue:5

    Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Forced Expiratory Volume; Humans; Norgestrel; Respiratory Mechanics

2003
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Contraception, 2006, Volume: 73, Issue:3

    Topics: Administration, Cutaneous; Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Factors; Thromboembolism

2006
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Contraception, 2006, Volume: 74, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Norgestrel; Pregnancy; Risk; Thromboembolism

2006
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Obstetrics and gynecology, 2007, Volume: 109, Issue:2 Pt 1

    Topics: Administration, Cutaneous; Brain Ischemia; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Myocardial Infarction; Norgestrel; Stroke; Thromboembolism; Venous Thrombosis

2007
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Contraception, 2007, Volume: 76, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Databases, Factual; Ethinyl Estradiol; Female; Humans; Managed Care Programs; Norgestrel; Risk Factors; Thromboembolism; United States

2007
[Acute cholestasis following treatment with nimesulide and oral contraception: case report and review].
    Vnitrni lekarstvi, 2008, Volume: 54, Issue:6

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestasis; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Humans; Liver; Norgestrel; Sulfonamides

2008
The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
    Antiviral therapy, 2011, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclopropanes; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Reverse Transcriptase Inhibitors; Young Adult

2011
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
    Antiviral therapy, 2011, Volume: 16, Issue:2

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Oligopeptides; Pyridines; Ritonavir; Women's Health; Young Adult

2011
Adolescents' experiences using the contraceptive patch versus pills.
    Journal of pediatric and adolescent gynecology, 2011, Volume: 24, Issue:4

    Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult

2011
Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.
    American journal of hematology, 2015, Volume: 90, Issue:8

    Topics: Adolescent; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral; Estrogen Receptor alpha; Ethinyl Estradiol; Factor V; Factor VIII; Female; Gene Expression; Heterozygote; Homozygote; Humans; Norgestrel; Polymorphism, Single Nucleotide; Protein S; Thrombin; Thrombomodulin; Thrombophilia; von Willebrand Factor; Young Adult

2015
Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Journal of women's health (2002), 2016, Volume: 25, Issue:6

    Topics: Adult; Blood Glucose; Carbohydrates; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Lipids; Norgestrel; Polycystic Ovary Syndrome

2016
UPLC-MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Apr-01, Volume: 1017-1018

    Topics: Chromatography, Liquid; Ethinyl Estradiol; Humans; Norgestrel; Quality Control; Reference Standards; Tandem Mass Spectrometry

2016
Simultaneous determination of estrogens (ethinylestradiol and norgestimate) concentrations in human and bovine serum albumin by use of fluorescence spectroscopy and multivariate regression analysis.
    Talanta, 2016, May-15, Volume: 152

    Topics: Animals; Cattle; Estrogens; Ethinyl Estradiol; Humans; Least-Squares Analysis; Multivariate Analysis; Norgestrel; Serum Albumin, Bovine; Spectrometry, Fluorescence; Time Factors

2016
The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
    The American journal of sports medicine, 2020, Volume: 48, Issue:1

    Topics: Androstenes; Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Norethindrone; Norgestrel; Progestins; Rats; Rats, Sprague-Dawley

2020
chemdatabank.com